We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+11.44%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$96.2B
AUM Growth
+$13.8B
(+17%)
Cap. Flow
+$2.5B
Cap. Flow
% of AUM
2.6%
Top 10 Holdings %
Top 10 Hldgs %
19.24%
Holding
5,235
New
767
Increased
1,692
Reduced
1,826
Closed
817
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$410M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$308M |
| 3 |
Eli Lilly
LLY
|
+$292M |
| 4 |
Costco
COST
|
+$291M |
| 5 |
Ford
F
|
+$257M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$368M |
| 3 |
Fair Isaac
FICO
|
+$197M |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$194M |
| 5 |
Carrier Global
CARR
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.55% |
| 2 | Consumer Discretionary | 7.1% |
| 3 | Financials | 4.87% |
| 4 | Healthcare | 4.79% |
| 5 | Industrials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4376
Century Therapeutics
IPSC
$381M
| $22.6K | ﹤0.01% |
40,480
-92,449
| -70% | -$49.6K |
|
|
LAR
4377
Lithium Argentina AG
LAR
$958M
| $22.3K | ﹤0.01% |
10,700
-4,797
| -31% | -$9.55K |
|
4378
PMV Pharmaceuticals
PMVP
$66.1M
| $22.2K | ﹤0.01% |
20,905
-991
| -5% | -$972 |
|
4379
PUT
Opendoor
OPEN
$3.7B
| $21.9K | ﹤0.01% |
42,470
-310
| -0.7% | -$224 |
|
|
URG
4380
Ur-Energy
URG
$485M
| $21.3K | ﹤0.01% |
20,253
-1,902
| -9% | -$1.52K |
|
4381
Spruce Power Holding Corp
SPRU
$39.9M
| $21K | ﹤0.01% |
+10,397
| New | +$20.3K |
|
4382
Allogene Therapeutics
ALLO
$601M
| $20.4K | ﹤0.01% |
18,066
-308,459
| -94% | -$410K |
|
4383
Fate Therapeutics
FATE
$281M
| $19.9K | ﹤0.01% |
+17,759
| New | +$20.6K |
|
|
SOL
4384
DELISTED
Emeren Group
SOL
| $18.8K | ﹤0.01% |
10,055
| – | – |
|
|
BOLD
4385
Boundless Bio
BOLD
$57.8M
| $18.6K | ﹤0.01% |
+18,399
| New | +$24.4K |
|
|
REE
4386
DELISTED
REE Automotive
REE
| $18.1K | ﹤0.01% |
30,465
+12,835
| +73% | +$22.6K |
|
4387
PUT
ChargePoint
CHPT
$133M
| $18K | ﹤0.01% |
1,280
-35
| -3% | -$469 |
|
4388
GrowGeneration
GRWG
$82.9M
| $17.6K | ﹤0.01% |
+18,807
| New | +$20.1K |
|
|
AIIO
4389
Robo.ai Inc
AIIO
$436M
| $16.7K | ﹤0.01% |
+522
| New | +$12.1K |
|
4390
Cytosorbents Corp
CTSO
$22.6M
| $15K | ﹤0.01% |
11,712
-28,837
| -71% | -$29K |
|
|
ALLR
4391
Allarity Therapeutics
ALLR
$18.9M
| $14.6K | ﹤0.01% |
+14,450
| New | +$13.7K |
|
4392
Gevo
GEVO
$396M
| $14.6K | ﹤0.01% |
11,031
-506,838
| -98% | -$594K |
|
|
OLPX
4393
DELISTED
Olaplex Holdings
OLPX
| $14.5K | ﹤0.01% |
+10,392
| New | +$13.5K |
|
4394
Solarmax Technology
SMXT
$19.4M
| $14.5K | ﹤0.01% |
+13,278
| New | +$15.1K |
|
4395
Veritone
VERI
$96.7M
| $14.1K | ﹤0.01% |
+11,200
| New | +$20.3K |
|
4396
PUT
Tilray
TLRY
$479M
| $13.9K | ﹤0.01% |
3,350
| – | – |
|
4397
Telomir Pharmaceuticals
TELO
$79.1M
| $13.5K | ﹤0.01% |
+10,829
| New | +$25K |
|
4398
SKYX Platforms
SKYX
$155M
| $13.2K | ﹤0.01% |
12,671
-63,169
| -83% | -$76.2K |
|
4399
SmartRent
SMRT
$183M
| $12K | ﹤0.01% |
+12,130
| New | +$10.8K |
|
|
4400
CALL
Opendoor
OPEN
$3.7B
| $11.7K | ﹤0.01% |
22,630
| – | – |
|
Similar funds
Squarepoint's Q2 2025 Portfolio in Review
As of Q2 2025, Squarepoint held 5,235 positions worth $96.2B, up 17% from $82.4B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Squarepoint's Q2 2025 filing shows 767 new, 1,692 increased, 1,826 reduced and 817 closed positions. Its largest new stake was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M. The largest sale was Microsoft, an estimated $1.48B.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Financials.
- Squarepoint's largest Q2 2025 buy was iShares MSCI EAFE ETF: 993,060 shares worth $88.8M.
- Squarepoint added most to Amazon in Q2 2025, an estimated $410M increase.
- Squarepoint's biggest Q2 2025 reduction was Microsoft, cutting an estimated $1.48B.
- Squarepoint fully exited State Street SPDR S&P 500 ETF Trust in Q2 2025, selling an estimated $194M.
- Squarepoint's ten largest holdings make up 19% of its $96.2B portfolio in Q2 2025.
- Squarepoint opened 767 new positions and closed 817 in Q2 2025.
- Squarepoint's portfolio value rose 17% quarter-over-quarter to $96.2B.
Based on Squarepoint's 13F filing for Q2 2025, filed 14 Aug 2025.